Andrea Tommasoli - 19 Mar 2023 Form 3 Insider Report for InspireMD, Inc. (NSPR)

Role
Chief Operating Officer
Signature
/s/ Andrea Tommasoli
Issuer symbol
NSPR
Transactions as of
19 Mar 2023
Net transactions value
$0
Form type
3
Filing time
20 Mar 2023, 08:33:12 UTC
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NSPR Common Stock 18,103 19 Mar 2023 Direct F1
holding NSPR Common Stock 59,270 19 Mar 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NSPR Option to Purchase Common Stock 19 Mar 2023 Common Stock 6,035 $5.25 Direct F3
holding NSPR Option to Purchase Common Stock 19 Mar 2023 Common Stock 19,756 $4.12 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's continued service.
F2 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.
F3 The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's continued service.
F4 The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.